<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00390663</url>
  </required_header>
  <id_info>
    <org_study_id>05/EN/03</org_study_id>
    <nct_id>NCT00390663</nct_id>
  </id_info>
  <brief_title>A Prospective Randomised Controlled Trial of Management of Recurrent Nosebleeds in Children</brief_title>
  <official_title>A Prospective Randomised Controlled Trial of Management of Recurrent Nosebleeds in Children: Antiseptic Cream Alone v's Antiseptic Cream With Nasal Cautery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NHS Greater Glasgow Yorkhill Division</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>NHS Greater Glasgow Yorkhill Division</source>
  <brief_summary>
    <textblock>
      To determine whether the selective application of a combined treatment regimen of silver
      nitrate cautery and 4 weeks of Naseptin cream is superior to naseptin treatment alone in the
      management of recurrent paediatric epistaxis.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2006</start_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <enrollment>216</enrollment>
  <condition>Epistaxis</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Nasal Cautery</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Children aged 1 - 14

          -  History of repeated epistaxis with at least 1 episode in the previous 4 weeks prior to
             attending the ENT clinic.

          -  Presence of prominent vessels on the anterior nasal septum on the side that reportedly
             bleeds (or on at least one side if bleeding is reported to be bilateral)

        Exclusion Criteria:

          -  No prominent vessels on examination (these children will be randomised but will be
             prescribed Naseptin alone and followed up in the same way as the children in the
             trial, for completeness of data)

          -  Known bleeding disorders.

          -  Allergy to peanuts, neomycin or chlorhexidine

          -  Other causes of nose bleeding eg tumour.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>14 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Haytham Kubba, MBBS(Hons) MPhil FRCS FRCSEd</last_name>
    <role>Principal Investigator</role>
    <affiliation>Royal Hospital for Sick Children</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Royal Hospital for Sick Children</name>
      <address>
        <city>Glasgow</city>
        <state>Strathclyde</state>
        <zip>G3 8SJ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Haytham Kubba</last_name>
      <phone>0141 201 1000</phone>
    </contact>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>October 2006</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 19, 2006</study_first_submitted>
  <study_first_submitted_qc>October 19, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 20, 2006</study_first_posted>
  <last_update_submitted>October 19, 2006</last_update_submitted>
  <last_update_submitted_qc>October 19, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 20, 2006</last_update_posted>
  <keyword>Paediatric</keyword>
  <keyword>Epistaxis</keyword>
  <keyword>Nose bleed</keyword>
  <keyword>Naseptin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epistaxis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

